Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 30,973 | 30,136 | 29,529 | 25,750 | 23,466 |
| Cost of Goods | 9,114 | 8,777 | 8,513 | 8,704 | 8,261 |
| Gross Profit | 21,859 | 21,359 | 21,016 | 17,046 | 15,205 |
| Operating Expenses | 23,736 | 25,236 | 23,596 | 20,807 | 19,770 |
| Operating Income | -1,763 | -3,100 | -2,067 | -3,057 | -4,304 |
| Interest Expense | 58 | 235 | 303 | 536 | 498 |
| Other Income | 1,091 | 841 | 453 | 488 | 333 |
| Pre-tax Income | -730 | -2,494 | -1,917 | -3,105 | -4,469 |
| Net Income Continuous | -730 | -2,494 | -1,917 | -3,105 | -4,469 |
| Net Income | $-730 | $-2,494 | $-1,917 | $-3,105 | $-4,469 |
| EPS Basic Total Ops | -0.02 | -0.05 | -0.05 | -0.05 | -0.12 |
| EPS Basic Continuous Ops | -0.02 | -0.05 | -0.05 | -0.06 | -0.12 |
| EPS Diluted Total Ops | -0.02 | -0.05 | -0.05 | -0.05 | -0.12 |
| EPS Diluted Continuous Ops | -0.02 | -0.05 | -0.05 | -0.06 | -0.12 |
| EBITDA(a) | $-796 | $-2,101 | $-1,114 | $-2,079 | $-3,315 |